NBC Connecticut: Beyond the Scale
Endometriosis Patients Report Relief After Using GLP-1s
Dr. Chandra Spring-Robinson and Savannah Regensburger Featured in NBC Connecticut’s “Beyond the Scale” Series
August 19, 2026
Could GLP-1 medications have a future role in endometriosis care?
It’s a question that Dr. Chandra Spring-Robinson, DO, FACOG and Savannah Regensburger, MS, MBA, CNS believe deserves much more research.
NBC Connecticut recently featured Dr. Spring-Robinson and Savannah in its Beyond the Scale series, examining emerging questions surrounding GLP-1 medications and women’s health.
The segment shares Savannah’s personal experience with endometriosis and tirzepatide, observations Dr. Spring-Robinson has made among some patients in her practice, and an important reality: there is still much we don’t know.Research specifically examining GLP-1 medications and endometriosis remains limited, and these medications are not FDA-approved for the treatment of endometriosis.
From a Patient’s Experience to a Research Question
Savannah’s journey with endometriosis began long before she became Dr. Spring-Robinson’s Clinical Nutritionist and Clinical Research Manager.
After excision surgery, Savannah continued to experience symptoms and flares. She later began tirzepatide under medical care and told NBC Connecticut that she experienced improvements in symptoms including bloating, brain fog, and the frequency of her flares. She described the changes as significant enough to help her return to activities and work that had previously become difficult.
Her experience is one patient’s experience, not clinical evidence that GLP-1 medications treat endometriosis.
But experiences like Savannah’s raise questions worth investigating.
Dr. Spring-Robinson told NBC Connecticut that she has observed improvements in inflammation and symptoms among some patients using GLP-1 medications. Those observations have now led Dr. Spring-Robinson and Savannah to begin developing research intended to more formally examine the potential relationship between GLP-1s and endometriosis.
Turning Questions Into Research 🔬
Dr. Spring-Robinson and Savannah are currently developing a proposed clinical research protocol examining GLP-1 medications and endometriosis.
The goal is not to position GLP-1s as a replacement for established endometriosis care or to assume an answer before the research is conducted.
The goal is to ask the question scientifically.
What effects, if any, might these medications have on symptoms, inflammation, quality of life, or other meaningful outcomes in women with endometriosis?
Those are questions that require carefully designed research.
As Dr. Spring-Robinson shared with NBC Connecticut, her larger goal is to continue identifying tools that may help women achieve a healthier quality of life.
Looking Beyond the Scale
NBC Connecticut’s broader Beyond the Scale series explores the rapidly evolving science surrounding GLP-1 medications, including their established uses as well as areas researchers are continuing to investigate. The series emphasizes the importance of appropriate medical oversight as this field continues to evolve.
For Dr. Spring-Robinson and Savannah, the endometriosis story represents the beginning of a much larger question.
Can observations from patients today help generate the research questions that improve endometriosis care tomorrow?
That’s what we hope to find out.